Glucose control during acute myocardial infarction

Internal Medicine Journal
N W Cheung

Abstract

The need for tight glycaemic control in the immediate aftermath of myocardial infarction is controversial. Trials of glucose-insulin-potassium (GIK) therapy, given without regard to glucose levels, have only confused the issue. Despite considerable clinical interest, only three randomized controlled trials have, as their primary goal, aimed to determine whether better glycaemic control improves the outcomes of myocardial infarction. This review examines the results of these trials and other data to support the case for tight glycaemic control in patients with myocardial infarction.

References

Jun 21, 1990·The New England Journal of Medicine·G DavìC Patrono
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Apr 18, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Yukitaka ShizukudaPeter M Buttrick
Feb 11, 2003·Critical Care Medicine·Greet Van den BerghePeter Lauwers
Mar 12, 2003·The Journal of Clinical Endocrinology and Metabolism·Troels Krarup HansenGreet Van den Berghe
Apr 6, 2004·Diabetes Research and Clinical Practice·Vincent W WongN Wah Cheung
Jan 27, 2005·JAMA : the Journal of the American Medical Association·Shamir R MehtaUNKNOWN CREATE-ECLA Trial Group Investigators
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Louis MonnierClaude Colette

❮ Previous
Next ❯

Citations

Apr 12, 2008·Internal Medicine Journal·R J Smith, M McLean
Apr 17, 2014·Nature Reviews. Cardiology·Sarah L LongnusHendrik T Tevaearai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.